OBI Pharma, Inc. (4174.TWO)
TWD 58.3
(-2.18%)
TWD 58.3
(-2.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 41.54 Million | 4.71 Million | 18.77 Million | 140.88 Million | 872 Thousand | 13.33 Million |
| Cost of Revenue | 115.04 Million | 44.85 Million | 44.36 Million | 6.46 Million | 226.32 Million | 5.28 Million |
| Gross Profit | -73.49 Million | -40.14 Million | -25.59 Million | 134.41 Million | -225.45 Million | 8.05 Million |
| Operating Expenses | 2.01 Billion | 2.08 Billion | 1.69 Billion | 1.6 Billion | 1.45 Billion | 1.43 Billion |
| Selling, General and Administrative Expenses | 319.27 Million | 309.76 Million | 240.82 Million | 290.41 Million | 267.53 Million | 308.65 Million |
| Research and Development Expenses | 1.69 Billion | 1.77 Billion | 1.44 Billion | 1.3 Billion | 1.18 Billion | 1.12 Billion |
| Other Expenses | - | 159.72 Million | -28.89 Million | -67.04 Million | 8.38 Million | 173.55 Million |
| Cost and Expenses | 2.13 Billion | 2.12 Billion | 1.73 Billion | 1.6 Billion | 1.45 Billion | 1.44 Billion |
| Operating Income | -2.08 Billion | -1.91 Billion | -1.73 Billion | -1.48 Billion | -1.44 Billion | -1.42 Billion |
| Interest Expense | 7.93 Million | 3.99 Million | 3.79 Million | 4.18 Million | 2.7 Million | 1.67 Million |
| Income Tax Expense | -9.59 Million | -17.76 Million | -24.36 Million | -3.79 Million | -5.59 Million | -6.3 Million |
| Earnings before Tax | -1.27 Billion | -1.91 Billion | -1.74 Billion | -1.49 Billion | -1.44 Billion | -1.25 Billion |
| Net Income | -1.04 Billion | -1.89 Billion | -1.71 Billion | -1.48 Billion | -1.43 Billion | -1.22 Billion |
| Earnings Per Share Basic | -4.54 | -8.55 | -8.55 | -7.43 | -7.43 | -7.06 |
| Earnings Per Share Diluted | -4.54 | -8.55 | -8.55 | -7.43 | -7.43 | -6.99 |
| Weighted Average Shares Outstanding | 230.41 Million | 222.12 Million | 200.95 Million | 200.59 Million | 193.71 Million | 173.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 230.41 Million | 222.12 Million | 200.95 Million | 200.59 Million | 193.71 Million | 174.83 Million |
| Gross Margin | -1.77 | -8.52 | -1.36 | 0.95 | -258.55 | 0.60 |
| EBIT Margin | -20.58 | -353.74 | -81.09 | -8.93 | -1462.22 | -84.83 |
| Profit Margin | -25.19 | -403.17 | -91.51 | -10.58 | -1650.91 | -91.63 |
| EBITDA | -855.08 Million | -1.66 Billion | -1.52 Billion | -1.25 Billion | -1.5 Billion | -1.13 Billion |
| Earnings Before Tax Margin | -50.30 | -406.09 | -92.61 | -10.57 | -1654.21 | -107.03 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 22.97 Million | 19.01 Million | 9.13 Million | 18.41 Million | 41.54 Million | 11.47 Million |
| Cost of Revenue | 38.05 Million | 86.96 Million | 88.59 Million | 32.62 Million | 115.04 Million | 32.93 Million |
| Gross Profit | -15.07 Million | -67.94 Million | -79.46 Million | -14.2 Million | -73.49 Million | -21.46 Million |
| Operating Expenses | 518.97 Million | 477.24 Million | 491.09 Million | 472.53 Million | 2.01 Billion | 596.53 Million |
| Selling, General and Administrative Expenses | - | 30.32 Million | 33.2 Million | 75.12 Million | - | 90 Million |
| Research and Development Expenses | - | 446.92 Million | 457.88 Million | 397.41 Million | - | 506.53 Million |
| Other Expenses | -518.97 Million | 9.13 Million | 71.23 Million | -472.53 Million | -2.01 Billion | 65.53 Million |
| Cost and Expenses | 557.03 Million | 564.2 Million | 579.68 Million | 505.16 Million | 2.13 Billion | 629.47 Million |
| Operating Income | -534.05 Million | -545.18 Million | -570.55 Million | -486.74 Million | -2.08 Billion | -623.5 Million |
| Interest Expense | - | 2.49 Million | 2.66 Million | 2.65 Million | 7.93 Million | 3.39 Million |
| Income Tax Expense | -17.9 Million | 2.5 Million | 1.74 Million | 2.78 Million | -9.59 Million | -13.38 Million |
| Earnings before Tax | -579.7 Million | -527.2 Million | -487.68 Million | -563.12 Million | -1.27 Billion | -626.89 Million |
| Net Income | -561.79 Million | -540.66 Million | -522.25 Million | -565.91 Million | -1.26 Billion | -567.83 Million |
| Earnings Per Share Basic | -2.25 | -2.36 | -2.28 | -2.47 | - | -2.48 |
| Earnings Per Share Diluted | -2.25 | -2.36 | -2.28 | -2.47 | - | -2.48 |
| Weighted Average Shares Outstanding | - | 229.24 Million | 229.24 Million | 229.06 Million | 229.05 Million | 229.08 Million |
| Weighted Average Shares Outstanding (Diluted) | - | 229.24 Million | 229.24 Million | 229.06 Million | 229.05 Million | 229.08 Million |
| Gross Margin | -0.66 | -3.57 | -8.70 | -0.77 | -1.77 | -1.87 |
| EBIT Margin | -23.24 | -25.83 | -56.62 | -27.37 | - | -48.46 |
| Profit Margin | -24.45 | -28.43 | -57.17 | -30.72 | -30.47 | -49.48 |
| EBITDA | -534.05 Million | -491.16 Million | -517.26 Million | -504.16 Million | - | -556.1 Million |
| Earnings Before Tax Margin | -23.24 | -28.67 | -62.46 | -26.43 | -50.30 | -54.33 |
F3A
2305
BURCF
RICA
DHG
3057